Rhythm completes cloning of key reagent ahead of schedule
Filed with ASX · · 2 pages · English
Rhythm Biosciences Limited on 6ix
Earlier from Rhythm Biosciences
- Rhythm Granted Biomarker Patent in Europe
- RHYs Four Antibodies Pass all Three Key Screening Tests
- Reagent Development Update
- Appendix 4D - Half Yearly Report
- Rhythm reports reagent development update
Later from Rhythm Biosciences
- Final Antibody Selection Complete
- AGM Presentation
- Appointment of CEO - Senior Management Changes
- Rhythm Completes Reagent Development Program
- Corporate Presentation
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences